Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect
A 15-year-old patient with acute lymphoblastic leukemia and Fusarium infection was treated with voriconazole. She developed asymptomatic bradycardia, QT interval prolongation, and nonsustained, polymorphic ventricular tachycardia, which recurred upon rechallenge with the drug. Voriconazole levels an...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
15 September 2004
|
| In: |
Clinical infectious diseases
Year: 2004, Volume: 39, Issue: 6, Pages: e49-e52 |
| ISSN: | 1537-6591 |
| DOI: | 10.1086/423275 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1086/423275 |
| Author Notes: | Y. Alkan, W.E. Haefeli, J. Burhenne, J. Stein, I. Yaniv, and I. Shalit |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1758146958 | ||
| 003 | DE-627 | ||
| 005 | 20230427100722.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210519s2004 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1086/423275 |2 doi | |
| 035 | |a (DE-627)1758146958 | ||
| 035 | |a (DE-599)KXP1758146958 | ||
| 035 | |a (OCoLC)1341413484 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Alkan, Yoav |e VerfasserIn |0 (DE-588)1233746405 |0 (DE-627)1758149337 |4 aut | |
| 245 | 1 | 0 | |a Voriconazole-induced QT interval prolongation and ventricular tachycardia |b a non-concentration-dependent adverse effect |c Y. Alkan, W.E. Haefeli, J. Burhenne, J. Stein, I. Yaniv, and I. Shalit |
| 264 | 1 | |c 15 September 2004 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.05.2021 | ||
| 520 | |a A 15-year-old patient with acute lymphoblastic leukemia and Fusarium infection was treated with voriconazole. She developed asymptomatic bradycardia, QT interval prolongation, and nonsustained, polymorphic ventricular tachycardia, which recurred upon rechallenge with the drug. Voriconazole levels and metabolism were within expected normal values. This non—concentration-dependent, voriconazole-associated ventricular tachycardia mandates cardiac rhythm monitoring during voriconazole treatment. | ||
| 700 | 1 | |a Haefeli, Walter E. |d 1958- |e VerfasserIn |0 (DE-588)124572359 |0 (DE-627)656806141 |0 (DE-576)340514221 |4 aut | |
| 700 | 1 | |a Burhenne, Jürgen |d 1963- |e VerfasserIn |0 (DE-588)1034228889 |0 (DE-627)745126987 |0 (DE-576)381858197 |4 aut | |
| 700 | 1 | |a Stein, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yaniv, I. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shalit, Itamar |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases |d Oxford : Oxford Journals, 1992 |g 39(2004), 6, Seite e49-e52 |h Online-Ressource |w (DE-627)320418308 |w (DE-600)2002229-3 |w (DE-576)090881834 |x 1537-6591 |7 nnas |a Voriconazole-induced QT interval prolongation and ventricular tachycardia a non-concentration-dependent adverse effect |
| 773 | 1 | 8 | |g volume:39 |g year:2004 |g number:6 |g pages:e49-e52 |g extent:4 |a Voriconazole-induced QT interval prolongation and ventricular tachycardia a non-concentration-dependent adverse effect |
| 856 | 4 | 0 | |u https://doi.org/10.1086/423275 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210519 | ||
| 993 | |a Article | ||
| 994 | |a 2004 | ||
| 998 | |g 1034228889 |a Burhenne, Jürgen |m 1034228889:Burhenne, Jürgen |d 910000 |d 910100 |e 910000PB1034228889 |e 910100PB1034228889 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 124572359 |a Haefeli, Walter E. |m 124572359:Haefeli, Walter E. |d 910000 |d 910100 |e 910000PH124572359 |e 910100PH124572359 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 999 | |a KXP-PPN1758146958 |e 3929592622 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"15 September 2004","dateIssuedKey":"2004"}],"person":[{"role":"aut","display":"Alkan, Yoav","family":"Alkan","given":"Yoav"},{"role":"aut","display":"Haefeli, Walter E.","family":"Haefeli","given":"Walter E."},{"given":"Jürgen","role":"aut","display":"Burhenne, Jürgen","family":"Burhenne"},{"given":"J.","display":"Stein, J.","role":"aut","family":"Stein"},{"given":"I.","family":"Yaniv","display":"Yaniv, I.","role":"aut"},{"role":"aut","display":"Shalit, Itamar","family":"Shalit","given":"Itamar"}],"title":[{"title_sort":"Voriconazole-induced QT interval prolongation and ventricular tachycardia","title":"Voriconazole-induced QT interval prolongation and ventricular tachycardia","subtitle":"a non-concentration-dependent adverse effect"}],"recId":"1758146958","language":["eng"],"physDesc":[{"extent":"4 S."}],"name":{"displayForm":["Y. Alkan, W.E. Haefeli, J. Burhenne, J. Stein, I. Yaniv, and I. Shalit"]},"id":{"doi":["10.1086/423275"],"eki":["1758146958"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 19.05.2021"],"relHost":[{"part":{"extent":"4","year":"2004","text":"39(2004), 6, Seite e49-e52","pages":"e49-e52","volume":"39","issue":"6"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"disp":"Voriconazole-induced QT interval prolongation and ventricular tachycardia a non-concentration-dependent adverse effectClinical infectious diseases","recId":"320418308","id":{"zdb":["2002229-3"],"eki":["320418308"],"issn":["1537-6591"]},"origin":[{"dateIssuedDisp":"1992-","publisherPlace":"Oxford ; Chicago, Ill.","publisher":"Oxford Journals ; Univ. of Chicago Press, Journals Division","dateIssuedKey":"1992"}],"pubHistory":["14.1992 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"Clinical infectious diseases","title":"Clinical infectious diseases","subtitle":"electronic edition"}],"note":["Gesehen am 31.07.2023"]}]} | ||
| SRT | |a ALKANYOAVHVORICONAZO1520 | ||